Chronic Kidney Disease [CKD] Nutritional Supplement Market (Nutrition Type: Amino Acid Supplements, Vitamin & Mineral Supplements, Probiotics, Prebiotics/Fibers, and Others) - Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2022-2030

The global Chronic Kidney Disease [CKD] Nutritional Supplement market size was estimated at USD 3.8 billion in 2021 and is expected to surpass around USD 5.20 billion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 4.10% during the forecast period 2022 to 2030.

Nutrition plays a vital role in chronic kidney disease (CKD) outcomes. The correlation between nutrition and chronic kidney disease is evident in many cases; dietary supplements helps facilitate patient recovery. For instance, micronutrients such as sodium and phosphorus are vital ingredients of dietary supplements and are being increasingly preferred over chronic kidney disease (CKD) drugs. Nutrition for advanced chronic kidney disease includes amino acid supplements, vitamin & mineral supplements, probiotics, prebiotics/fibers, and herbal supplements. A person may prevent or delay some health issues from chronic kidney disease by choosing the right foods and avoiding foods high in sodium, potassium, and phosphorus.

Increase in geriatric population, rise in prevalence of chronic kidney disease (CKD), surge in usage of medical food supplements for chronic renal failure, and growth in sales through e-commerce platforms are the major factors propelling the global market. Geriatric population is increasing across the globe. This population is more prone to chronic diseases such as chronic kidney disease. According to the United Nations World Population Ageing 2019 report, 703 million people were aged 65 years or above globally in 2019, which is projected to double to reach 1.9 billion by 2050. According to recent estimates from researchers at the Johns Hopkins University, more than 50% of individuals over the age of 75 are believed to have kidney disease. Kidney disease has also been found to be more prevalent in those over the age of 60 compared to the rest of the general population.

Report Scope of the Chronic Kidney Disease [CKD] Nutritional Supplement Market

According to Centers for Disease Control and Prevention (CDC) estimates published in March 2021, CKD is more common in individuals aged 65 years or older (38%) than in people aged 45–64 years (12%) or 18–44 years (6%). CKD is slightly more common in women (14%) than men (12%). The CDC stated that more than one in 7 (15%) of the U.S. adults, or 37 million patients, are estimated to have CKD currently.

The global estimated prevalence of CKD is 13.4% (11.7%–15.1%), and patients with end-stage kidney disease (ESKD) needing renal replacement therapy is estimated between 4.90 million and 7.08 million. In 2017, the global prevalence of CKD stood at 9.1% or about 700 million cases. CKD is a major public health issue in low- and middle-income countries (LMICs). Its prevalence has been increasing rapidly in these countries, particularly in countries in Asia.

The chronic kidney disease population utilizes nutritional supplements for CKD treatment. According to the Mayo Clinic researchers (September 2019), more than one-third of the 15.7 million (~5.3 billion) Americans with moderate or advanced CKD use dietary or herbal supplements.

The Orphan Drug Act defined medical food as the food that is formulated to be consumed or administered by enteral route under the supervision of a physician, and which is intended for a specific diet. Manufacturers are marketing an array of medical foods, ranging from powders and capsules for chronic kidney disease treatment. Nestlé has been pivoting to carve a niche in the medical food business and home in on personal nutrition. In August 2019, Nestlé Health Science, a wholly owned subsidiary of Nestlé S.A., acquired Persona Nutrition (formerly Vitamin Packs, Inc.) in order to gain a foothold in the personal nutrition segment. Personal nutrition includes dietary supplements, wellness products, nutraceuticals, and functional foods that help aid overall well-being or performance.

COVID-19 Impact on Global Chronic Kidney Disease Nutritional Supplement Market

COVID-19 has had a positive effect on the global chronic kidney disease nutritional supplement size. The unprecedented outbreak of the COVID-19 pandemic has largely affected countries in North America and Europe such as the U.S., Italy, Spain, the U.K., France, and Germany. The dietary supplement industry is concentrated in these regions. The industry has benefited from the pandemic situation, as the market witnessed a surge in demand for immunity-boosting supplements. Immunity-boosting vitamins, minerals, and herbs witnessed a rise in demand in 2020, which is expected to continue till the COVID-19 vaccine reaches everyone. The spread of the COVID-19 has attracted more customer traffic to comprehensive e-commerce platforms, resulting in the easy availability of various supplement brands for consumers. Online purchasing habits of consumers developed during the pandemic are expected to continue over the next few years as well.

Increase in Need for Water Soluble Vitamins for CKD Patients Driving Vitamin & Mineral Supplements Segment

In terms of nutrition type, the vitamin & mineral supplements segment held the largest share of the global chronic kidney disease nutritional supplement market in 2021. Rise in need for water soluble vitamins (vitamin B, C & D) for CKD patients is propelling the segment. Vitamin C could be suggested in low dosages; large doses can cause a buildup of oxalate. B complex vitamins, iron, vitamin C, vitamin D, calcium, and phosphate are used in supplements consumed by CKD patients. Minerals, including calcium and phosphate, are consumed to help maintain bones.

The amino acid supplements segment is likely to witness significant growth during the forecast period. Alpha ketoanalogue (α-ketoanalogue) is commonly used as nutrition therapy or dietary supplement in patients with chronic kidney disease. It slows down the progression of kidney disease, improves the quality of life, and enhances calcium and phosphate metabolism.

Higher Efficiency and Easy Availability Fueling Capsule Segment

In terms of dosage form, the capsule segment held the largest share of the global chronic kidney disease nutritional supplement market in 2021. The trend is anticipated to continue during the forecast period. This can be ascribed to the rise in acceptance of capsules over other dosage forms, as they are easier to swallow, convenient, and have a higher perceived efficiency as well as higher availability in the market.

Clinical Benefits and Lower Healthcare Costs Augmenting Enteral Nutrition Segment

Based on FSMP mode of administration, the enteral nutrition segment is anticipated to grow at a faster CAGR from 2022 to 2030. Enteral nutrition with foods for special medical purposes (FSMP) is recommended for most patients on home enteral nutrition. Several studies have demonstrated that enteral nutrition can provide clinical benefits at lower healthcare costs by reducing the length of hospital stays.

Increase in ESRD Patient Population Propelling End-stage Renal Disease Segment

In terms of CKD stage, the end-stage renal disease segment accounted for significant share of the global chronic kidney disease nutritional supplement market in 2021. This can be ascribed to the increase in number of patients suffering from severe kidney failure, rapid rise in number of hospitals & urgent care centers, and surge in hospital admission rates. According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), nearly 786,000 people in the U.S. are living with end stage kidney disease (ESKD), also known as end-stage renal disease (ESRD).

Surge in Hospital Admission Rate Bolstering Hospital Pharmacies Segment

Based on distribution channel, the hospital pharmacies segment accounted for the largest share of the global chronic kidney disease nutritional supplement market in 2021. This can be ascribed to the increase in number of hospital pharmacies, rise in hospital admissions, developing healthcare infrastructure, and surge in usage of CKD nutritional supplements in dialysis patients. Currently, the U.S. has 28,738 pharmacies and drug stores, an increase of 1.7% from that in 2021. According to statistics published by the American Hospital Association (AHA), the country has 6,093 hospitals. This represents a strong base of hospital pharmacies in the country, which contributes to regional growth.

Regional Analysis of Global Chronic Kidney Disease Nutritional Supplement Market

North America accounted for the largest share of the global chronic kidney disease nutritional supplement market in 2021. The trend is expected to continue during the forecast period. Growth of the market in the region can be ascribed to the presence of leading players, favorable reimbursement policies, and well-established healthcare infrastructure.

Asia Pacific is likely to capture the largest share of the global market during the forecast period due to surge in geriatric population, larger CKD patient population base, developing healthcare infrastructure, and increase in incidence of diabetes. Rise in interest of key international companies in expanding their production bases and product portfolio in countries in Asia and Southeast Asia such as South Korea, Malaysia, India, and China due to high population density is expected to propel the market in the region during the forecast period. According to the United Nations Population Fund (UNFPA), one in four people in Asia and the Pacific will be above 60 years old by 2050. The population of older persons (aged more than 60) in the region will triple between 2010 and 2050, reaching close to 1.3 billion.

Analysis of Key Players in Global Chronic Kidney Disease Nutritional Supplement Market

The report concludes with the company profiles section that includes key information about the major players in the global chronic kidney disease nutritional supplement market. Market participants focus on strategies such as new product launches, mergers & acquisitions (M&As), and public & private partnerships to strengthen their position. Abbott Laboratories, Ajanta Pharma Limited, Fresenius Kabi AG, Hexagon Nutrition Limited, Mankind Pharma Ltd., Nestlé S.A., Nutricia Limited (Danone S.A.), PRINE Health MSO, LLC, and RPG Life Sciences Limited are the prominent players operating in the global market.

Key Developments in Global Chronic Kidney Disease Nutritional Supplement Market

• In March 2021, Mankind Pharma Ltd. launched Health OK multivitamin tablet and food supplement. This product helps cope with modern lifestyle illnesses. It comprises formulations of natural ginseng and taurine for maintaining energy, 20 multivitamins and minerals for improving overall health and vitamin C, D, and zinc for building immunity. Health OK tablet restores the body’s essential vitamins and minerals and helps in healing wounds, boosting the immune system, repairing cells that are damaged by free radicals, strengthening bones, and converting food into energy.
• In February 2019, Fresenius SE & Co. KGaA completed the acquisition of NxStage Medical, Inc. (NxStage), following approval by antitrust authorities in the U.S. NxStage produces, develops, and markets an innovative product portfolio of medical devices for usage in home dialysis and critical care. The acquisition would enable Fresenius Medical Care to leverage its manufacturing, supply chain, and marketing competencies across dialysis products, services, and care coordination businesses in a less labor- and capital-intensive care setting.

Some of the prominent players in the Chronic Kidney Disease [CKD] Nutritional Supplement Market include:

• Abbott Laboratories
• Ajanta Pharma Limited
• Fresenius Kabi AG
• Hexagon Nutrition Limited
• Mankind Pharma Ltd.
• Nestlé S.A.
• Nutricia Limited (Danone S.A.)
• PRINE Health MSO, LLC
• RPG Life Sciences Limited

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Chronic Kidney Disease [CKD] Nutritional Supplement market

• Nutrition Type
• Amino Acid Supplements
• Alpha-Ketoanalogue Supplements
• Alpha Lipoic Acid Supplements
• Others
• Vitamin & Mineral Supplements
• Probiotics
• Prebiotics / Fibers
• Others
• Dosage Form
• Capsule
• Liquid
• Powder
• Others
• FSMP Mode of Administration
• Oral Nutrition (ON)
• Enteral Nutrition (EN)
• CKD Stage
• Pre-dialysis Stage 1-2
• Pre-dialysis Stage 3-5
• Dialysis
• End-stage Renal Disease
• Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Stores

By Geography

North America

• U.S.
• Canada

Europe

• Germany
• France
• United Kingdom
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Southeast Asia
• Rest of Asia Pacific

Latin America

• Brazil
• Rest of Latin America

Middle East & Africa (MEA)

• GCC
• North Africa
• South Africa
• Rest of Middle East & Africa

Key Benefits for Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the global Chronic Kidney Disease [CKD] Nutritional Supplement industry analysis from 2022 to 2030 to identify the prevailing Chronic Kidney Disease [CKD] Nutritional Supplement industry opportunity.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the global Chronic Kidney Disease [CKD] Nutritional Supplement industry segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global Chronic Kidney Disease [CKD] Nutritional Supplement industry trends, key players, market segments, application areas, and market growth strategies.